$82.66
-4.28 (-4.92%)
At Close: Aug 05, 2026
3 Overvalued S&P 500 Stocks for Your ‘Do NOT Buy' List
04:48pm, Monday, 01'st Apr 2024
BNN Bloomberg reported in July 2023 that the S&P 500 was overvalued by about 8%, according to Cresset Capital Chief Information Officer Jack Ablin. In the eight months since, it's up another 19%, prov
DexCom (DXCM) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Friday, 29'th Mar 2024
DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
International Companies Drive Diabesity Innovation
09:59am, Friday, 29'th Mar 2024
International Companies Drive Diabesity Innovation
DexCom (DXCM) Hits 52-Week High: What's Driving the Stock?
12:01pm, Wednesday, 27'th Mar 2024
Investors are optimistic about DexCom's (DXCM) strong product portfolio.
Has DexCom (DXCM) Outpaced Other Medical Stocks This Year?
10:46am, Tuesday, 26'th Mar 2024
Here is how DexCom (DXCM) and Anika Therapeutics (ANIK) have performed compared to their sector so far this year.
More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy'
02:04pm, Monday, 25'th Mar 2024
Investors got a good case of whiplash over the past four years. The pandemic crash of 2020 brought a decade-long bull market to a screeching halt.
S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind
08:00am, Saturday, 23'rd Mar 2024
S&P 500 stocks DexCom, Blackstone and Royal Caribbean lead five stocks around buy points after Fed chief Jerome Powell helped buoy markets.
DexCom, Inc. (DXCM) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Thursday, 21'st Mar 2024
Zacks.com users have recently been watching DexCom (DXCM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
DexCom (DXCM) Stock Sinks As Market Gains: Here's Why
07:05pm, Tuesday, 19'th Mar 2024
DexCom (DXCM) closed at $134.17 in the latest trading session, marking a -0.41% move from the prior day.
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now
10:31am, Monday, 18'th Mar 2024
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
Buy 5 Medical Devices Stocks for a Stable Portfolio in 2024
10:51am, Thursday, 14'th Mar 2024
We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These are: AORT, TMDX, DXCM, SWAV, EW.
Is It Worth Investing in DexCom (DXCM) Based on Wall Street's Bullish Views?
10:30am, Thursday, 14'th Mar 2024
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Medical Devices ETF Hits 52-Week High: Stocks to Watch
01:41pm, Wednesday, 13'th Mar 2024
Historically viewed as a defensive area, health care also boasts many growth aspects and benefits from advances in technology.
DexCom (DXCM) Sees a More Significant Dip Than Broader Market: Some Facts to Know
07:06pm, Monday, 11'th Mar 2024
The latest trading day saw DexCom (DXCM) settling at $133.04, representing a -1.63% change from its previous close.
2 Medical Device Stocks to Buy Hand Over Fist in March
09:15am, Friday, 08'th Mar 2024
Medtronic is a leading medical device maker that continues to get bigger and more diversified. DexCom's continuous glucose monitoring devices are crucial for diabetics, enabling strong growth.
Sign In
Buy DXCM